The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients.
Methadone-maintained pregnant patients with mood disorders have compromised treatment outcomes ( [1] ). This study examined the relationship between the presence of mood disorders and delivery and neonatal outcomes. Participants were categorized into two groups: no current mood disorder (n = 30) or primary mood disorder (n = 38). The mood disorder group reported more serious lifetime and current depression than did the no current mood disorder group. Neonates from mothers with mood disorders had a longer length of stay in the neonatal intensive care unit than the no current mood disorder group. Findings emphasize the need to treat mood disorders in methadone-maintained pregnant patients.
Tuten
Michelle
M
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. mtuten@jhmi.edu
Heil
Sarah H
SH
O'Grady
Kevin E
KE
Fitzsimons
Heather
H
Chisolm
Margaret S
MS
Jones
Hendrée E
HE
D000328:Adult; D000704:Analysis of Variance; D016009:Chi-Square Distribution; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D005831:Genital Diseases, Female; D006801:Humans; D007231:Infant, Newborn; D007902:Length of Stay; D008431:Maternal-Fetal Exchange; D008691:Methadone / Q000627:therapeutic use*; D019964:Mood Disorders / Q000150:complications*; D009294:Narcotics / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000150:complications* / Q000188:drug therapy*; D018579:Patient Selection; D011247:Pregnancy; D011256:Pregnancy Outcome; D016896:Treatment Outcome
D009294:Narcotics; D008691:Methadone